Compound or practice · Supplement

Cinnamon

A modest, inconsistent glucose helper — and a reminder that cassia cinnamon's coumarin can stress the liver at high doses.

Overall grade
Grade C
Last revised
1
graded outcome
0
references listed

A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.

1 at grade C — 1 graded row

What is known

Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.

  • Fasting glucoseEvidence grade C

    Inconsistent

    Smallmixed

What is uncertain

Read off the same rows as above. Nothing here is added that the entry does not itself record.

  • Thin evidence: Fasting glucose (grade C).
  • Caution with Metformin: Additive glucose lowering.

Interactions

Documented pairings with supplements and medicines. A medicine on this list is a conversation for whoever prescribes it.

  • MetforminCaution

    Additive glucose lowering.

The evidence in words

What it is

Cinnamon (cassia or Ceylon) is a spice studied for blood-glucose control. Cassia is common and cheap; Ceylon is lower in coumarin.

How it works

Cinnamon polyphenols may improve insulin sensitivity and slow gastric emptying, modestly affecting post-meal glucose.

What the evidence shows

Meta-analyses show small, inconsistent reductions in fasting glucose and lipids — real for some, negligible for others, and not a substitute for glucose-lowering therapy. The safety caveat: cassia cinnamon contains coumarin, which is hepatotoxic in high chronic doses; Ceylon avoids this.

How to use it

1–2 g/day; prefer Ceylon cinnamon for regular supplemental use to limit coumarin.

Safety & interactions

High-dose cassia coumarin can stress the liver; additive glucose lowering with diabetes drugs. metformin — Additive glucose lowering.

Bottom line

A mild, unreliable glucose nudge. If you use it daily, choose Ceylon over cassia to avoid the coumarin liver risk.

How it is used

As the entry records it, from the studies it summarises. Not a recommendation for you — doses that suit a trial population may not suit you.

Standard
1–2 g/day; prefer Ceylon.

Entries that share this one's tags or conditions.

Sources

This entry lists no references of its own.

Last revised . A grade is this entry's reading of the evidence, not medical advice.